Table 4.
Author, P. year | Country, income | Study setting | Study design | Sample size | weeks | Screening tool used | Infant adverse health outcomes | Estimate (RR/OR) | LCI | UCI |
---|---|---|---|---|---|---|---|---|---|---|
Hasselmann MH et al. 2008 | Brazil, Middle | HI | cohort | 429 | 4 to 8 weeks | EPDS | Non-EB | 1.21 | 1.02 | 1.45 |
Surkan PJ et al. 2008 | Brazil, Middle | HI | cross sectional | 595 | 6 to 12 months | CES-D | Short stature | 1.8 | 1.1 | 2.9 |
Machado MC et al. 2014 | Brazil, Middle | HI | longitudinal | 168 | 1 to 3 months | EPDS | Non-EB | 1.61 | 1.19 | 2.19 |
Gausia K et al. 2010 | Bangladish, Low | Community | longitudinal | 318 | 6 to 8 weeks | EPDS | Diarrhea | 1.74 | 1.25 | 3.42 |
Rahman A et al. 2016 | Pakistan, Low | Community | cohort | 279 | 6 months | DSM-IV | Non-EB | 1.42 | 0.98 | 2.06 |
Upadhyay AK et al. 2016 | India, Middle | Community | longitudinal | 1833 | 5 to 21 months | SRQ-20 | Stunting | 1.53 | 1.21 | 1.92 |
Islam MJ et al. 2017 | Bangladish, Low | Community | cross sectional | 426 | 6 months | EPDS | Non-EB | 5 | 2.27 | 11.11 |
Saeed Q et al. 2016 | Pakistan, Low | Community | cross sectional | 325 | 2 years | AKUAD | Stunting | 3.15 | 1.91 | 5.18 |
Underweight | 3.26 | 1.99 | 5.34 | |||||||
Adewuya AO et al. 2007 | Nigeria, Middle | HI | case control | 242 | 6 to 12 weeks | SCID-NP | Poor weight | 3.41 | 1.3 | 8.52 |
Poor height | 3.28 | 1.03 | 10.47 | |||||||
Guo N et al. 2013 | Ghana, Middle | HI | Longitudinal | 654 | 3 months | PHQ | Febrile illnesses | 1.32 | 1.01 | 1.74 |
Guo N et al. 2013 | Côte d’Ivoire Middle | Febrile illnesses | 1.57 | 1.20 | 2.07 | |||||
Ashaba Set al 2013 | Uganda, Low | HI | Case control | 166 | 1–5 yrs | (M.I.N.I.) | Malnutrition | 2.4 | 1.11 | 5.18 |
Weobong B et al. 2017 | Ghana, Middle | Community | Longitudinal | 16,560 | 4 to 12 weeks | DSM-IV | Diarrhea | 1.8 | 1.45 | 2.14 |
cough | 1.49 | 1.28 | 1.7 | |||||||
Fever | 1.8 | 1.49 | 2.11 | |||||||
Vomiting | 1.98 | 1.26 | 2.71 | |||||||
Madeghe BA et al. 2016 | Kenya, Middle | HI | Cross-sectional | 200 | 6 to 14 weeks | EPDS | Non-EB | 6.14 | 2.45 | 13.36 |
Underweight | 4.4 | 1.91 | 11.93 | |||||||
Wemakor A et al. 2016 | Ghana, Middle | HI | Cross-sectional | 384 | 0–59 months | CED-S | Stunting | 2.48 | 1.29 | 4.77 |
Ndokera R et al. 2008 | Zambia, Middle | community | Cross-sectional | 278 | 2–12 months | CED | serious illness | 1.64 | 0.51 | 5.24 |
diarrhea | 1.32 | 0.71 | 2.48 | |||||||
underweight | 1.48 | 0.35 | 6.22 | |||||||
Maureen M Black et al. 2009 | Bangladish, Low | Community | cross sectional | 221 | 6–12 months | CED | Stunting | 2.17 | 1.24 | 3.81 |
Benett IM et al. 2015 | India, Middle | community | Longitudinal | 1930 | 12 months | CED | Stunting | 1.18 | 1.03 | 1.35 |
Underweight | 1.11 | 0.97 | 1.26 | |||||||
Ethiopia, Low | 1885 | Stunting | 0.91 | 0.81 | 1.02 | |||||
Underweight | 1.01 | 0.89 | 1.15 | |||||||
Peru, Low | 1946 | Stunting | 1.06 | 0.93 | 1.22 | |||||
underweight | 0.85 | 0.6 | 1.19 | |||||||
Vietnam Low | 1961 | Stunting | 0.91 | 0.81 | 1.02 | |||||
Underweight | 1.29 | 1.03 | 1.62 |